XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In- Capital
Treasury Stock
Accumulated Deficit
Noncontrolling Interest
Cumulative Effect Period Of Adoption Adjustment
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect change in accounting principle $ 1,018,413 $ 1,968 $ 4,151,147 $ (64,940) $ (3,069,272) $ (490) $ (55,885)
Balances at beginning of period at Dec. 31, 2018 1,018,413 1,968 4,151,147 (64,940) (3,069,272) (490) (55,885)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan   2 878        
Issuance of warrants     0        
Restricted stock, net   31 (31)        
Shares withheld for employee taxes   (4) (3,238)        
Other, net     75        
Compensation expense related to restricted stock grants     18,315        
Purchase of treasury stock       (14,157)      
Net income (loss) (177,169)       (176,523) (646)  
Noncontrolling interest contribution           6,566  
Cumulative effect change in accounting principle 793,796 1,997 4,167,146 (79,097) (3,301,680) 5,430 (55,885)
Balances at end of period at Sep. 30, 2019 793,796 $ 1,997 4,167,146 (79,097) (3,301,680) 5,430  
Balances at beginning of period (in shares) at Dec. 31, 2018   192,356,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan (in shares)   137,000          
Restricted stock grants, net (in shares)   3,258,000          
Shares withheld for employee taxes (in shares)   (467,000)          
Purchase of treasury stock (in shares)   (2,211,000)          
Balances at end of period (in shares) at Sep. 30, 2019   193,073,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect change in accounting principle 866,204 $ 1,998 4,161,045 (79,097) (3,223,222) 5,480 0
Balances at beginning of period at Jun. 30, 2019 866,204 1,998 4,161,045 (79,097) (3,223,222) 5,480 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan   0 281        
Issuance of warrants     0        
Restricted stock, net   (1) 1        
Shares withheld for employee taxes   0 (137)        
Other, net     27        
Compensation expense related to restricted stock grants     5,929        
Purchase of treasury stock       0      
Net income (loss) (78,508)       (78,458) (50)  
Noncontrolling interest contribution           0  
Cumulative effect change in accounting principle 793,796 1,997 4,167,146 (79,097) (3,301,680) 5,430 0
Balances at end of period at Sep. 30, 2019 793,796 $ 1,997 4,167,146 (79,097) (3,301,680) 5,430  
Balances at beginning of period (in shares) at Jun. 30, 2019   193,111,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan (in shares)   41,000          
Restricted stock grants, net (in shares)   (62,000)          
Shares withheld for employee taxes (in shares)   (17,000)          
Purchase of treasury stock (in shares)   0          
Balances at end of period (in shares) at Sep. 30, 2019   193,073,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect change in accounting principle 793,796 $ 1,997 4,167,146 (79,097) (3,301,680) 5,430  
Cumulative effect change in accounting principle 698,725 1,996 4,172,099 (84,651) (3,393,088) 2,369 (115)
Balances at beginning of period at Dec. 31, 2019 698,725 1,996 4,172,099 (84,651) (3,393,088) 2,369 (115)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan   2 468        
Issuance of warrants     22,883        
Restricted stock, net   (8) 8        
Shares withheld for employee taxes   (6) (4,012)        
Other, net     52        
Compensation expense related to restricted stock grants     18,212        
Purchase of treasury stock       (18,123)      
Net income (loss) 126,084       126,139 (55)  
Noncontrolling interest contribution           0  
Cumulative effect change in accounting principle 698,725 1,984 4,209,710 (102,774) (3,267,064) 2,314 (115)
Balances at end of period at Sep. 30, 2020 $ 844,170 $ 1,984 4,209,710 (102,774) (3,267,064) 2,314  
Balances at beginning of period (in shares) at Dec. 31, 2019 192,128,586 192,129,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan (in shares)   182,000          
Restricted stock grants, net (in shares)   (683,000)          
Shares withheld for employee taxes (in shares)   (650,000)          
Purchase of treasury stock (in shares)   (3,063,000)          
Balances at end of period (in shares) at Sep. 30, 2020 187,914,958 187,915,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect change in accounting principle $ 939,889 $ 1,984 4,180,436 (102,774) (3,142,089) 2,332 0
Balances at beginning of period at Jun. 30, 2020 939,889 1,984 4,180,436 (102,774) (3,142,089) 2,332 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan   1 300        
Issuance of warrants     22,883        
Restricted stock, net   (1) 1        
Shares withheld for employee taxes   0 (61)        
Other, net     15        
Compensation expense related to restricted stock grants     6,136        
Purchase of treasury stock       0      
Net income (loss) (124,993)       (124,975) (18)  
Noncontrolling interest contribution           0  
Cumulative effect change in accounting principle 939,889 1,984 4,209,710 (102,774) (3,267,064) 2,314 $ 0
Balances at end of period at Sep. 30, 2020 $ 844,170 $ 1,984 4,209,710 (102,774) (3,267,064) 2,314  
Balances at beginning of period (in shares) at Jun. 30, 2020   187,920,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan (in shares)   121,000          
Restricted stock grants, net (in shares)   (104,000)          
Shares withheld for employee taxes (in shares)   (22,000)          
Purchase of treasury stock (in shares)   0          
Balances at end of period (in shares) at Sep. 30, 2020 187,914,958 187,915,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect change in accounting principle $ 844,170 $ 1,984 $ 4,209,710 $ (102,774) $ (3,267,064) $ 2,314